tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PCVX Stock Latest News

Vaxcyte’s Promising Prospects: Buy Rating Reinforced by Positive Phase 2 Data and Strategic Expansion
RatingsVaxcyte’s Promising Prospects: Buy Rating Reinforced by Positive Phase 2 Data and Strategic Expansion
10d ago
PCVX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
16d ago
CDT
HUT
Optimistic Buy Rating for Vaxcyte Amid Vaccine Development Challenges and Strategic Adjustments
PremiumRatings
Optimistic Buy Rating for Vaxcyte Amid Vaccine Development Challenges and Strategic Adjustments
17d ago
PCVX
BofA lowers Vaxcyte price target, says selloff after infant data ‘overdone’
PremiumThe Fly
BofA lowers Vaxcyte price target, says selloff after infant data ‘overdone’
17d ago
PCVX
Vaxcyte’s Promising Vaccine Potential and Market Expansion Drive Buy Rating
PremiumRatings
Vaxcyte’s Promising Vaccine Potential and Market Expansion Drive Buy Rating
17d ago
PCVX
Vaxcyte’s Strong Phase 2 Data and Future Prospects Justify Buy Rating Despite Market Overreaction
PremiumRatingsVaxcyte’s Strong Phase 2 Data and Future Prospects Justify Buy Rating Despite Market Overreaction
18d ago
PCVX
Vaxcyte price target lowered to $90 from $140 at Needham
Premium
The Fly
Vaxcyte price target lowered to $90 from $140 at Needham
18d ago
PCVX
Vaxcyte’s VAX-24: Promising Infant Vaccine Results Amidst Investor Concerns
Premium
Ratings
Vaxcyte’s VAX-24: Promising Infant Vaccine Results Amidst Investor Concerns
18d ago
PCVX
Optimistic Outlook for Vaxcyte: Potential for Improved Vaccine Efficacy in Future Trials
PremiumRatings
Optimistic Outlook for Vaxcyte: Potential for Improved Vaccine Efficacy in Future Trials
18d ago
PCVX
Vaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISI
PremiumThe Fly
Vaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISI
18d ago
PCVX
Rocket acquires Mr. Cooper, Musk’s xAI acquires X: Morning Buzz
PremiumThe Fly
Rocket acquires Mr. Cooper, Musk’s xAI acquires X: Morning Buzz
18d ago
X
GT
Morning Movers: Mr. Cooper surges after Rocket Companies takeover deal
PremiumThe Fly
Morning Movers: Mr. Cooper surges after Rocket Companies takeover deal
18d ago
FBK
HUT
Vaxcyte Announces Positive Phase 2 Results for VAX-24
PremiumCompany AnnouncementsVaxcyte Announces Positive Phase 2 Results for VAX-24
18d ago
8K
PCVX
Vaxcyte vaccine data ‘slightly’ miss Street bogey, says Mizuho
Premium
The Fly
Vaxcyte vaccine data ‘slightly’ miss Street bogey, says Mizuho
18d ago
PCVX
Vaxcyte sinks 35% to $45 after pneumococcal disease vaccine results
Premium
The Fly
Vaxcyte sinks 35% to $45 after pneumococcal disease vaccine results
18d ago
PCVX
Vaxcyte reports topline results from VAX-24 infant Phase 2 dose-finding study
PremiumThe Fly
Vaxcyte reports topline results from VAX-24 infant Phase 2 dose-finding study
18d ago
PCVX
Goldman Sachs Says It’s Time to Pull the Trigger on Healthcare Stocks — Here Are 2 Names to Pounce on Now
PremiumStock Analysis & Ideas
Goldman Sachs Says It’s Time to Pull the Trigger on Healthcare Stocks — Here Are 2 Names to Pounce on Now
1M ago
MDGL
PCVX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
IPA
PBM
Vaxcyte’s Earnings Call Highlights Strong Position and Future Growth
PremiumCompany Announcements
Vaxcyte’s Earnings Call Highlights Strong Position and Future Growth
2M ago
PCVX
Vaxcyte’s Promising Prospects and Strategic Engagements Justify Buy Rating
PremiumRatingsVaxcyte’s Promising Prospects and Strategic Engagements Justify Buy Rating
2M ago
PCVX
Promising Outlook for Vaxcyte: Strong Execution and Financial Position Support Buy Rating
Premium
Ratings
Promising Outlook for Vaxcyte: Strong Execution and Financial Position Support Buy Rating
2M ago
PCVX
Buy Rating for Vaxcyte Driven by Anticipated Positive Phase 2 Data and Undervalued Stock Potential
Premium
Ratings
Buy Rating for Vaxcyte Driven by Anticipated Positive Phase 2 Data and Undervalued Stock Potential
2M ago
PCVX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >